New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
How does type 1 diabetes alter muscle structure and blood supply?

How does type 1 diabetes alter muscle structure and blood supply?

by Association of Basic Medical Sciences of FBIHExpression of myosin heavy chain isoforms 1 (A, E), 2a (B, F), 2x/d (C, G), and 2b (D, H) in successive cross-sections of gluteus maximusmuscle of
Diabetes & Endocrinology March 14,2024
How does type 1 diabetes alter muscle structure and blood supply?

How does type 1 diabetes alter muscle structure and blood supply?

by Association of Basic Medical Sciences of FBIHExpression of myosin heavy chain isoforms 1 (A, E), 2a (B, F), 2x/d (C, G), and 2b (D, H) in successive cross-sections of gluteus maximusmuscle of
Diabetes & Endocrinology March 14,2024
cfDNA sequencing enhances non-invasive early detection of gestational diabetes

cfDNA sequencing enhances non-invasive early detection of gestational diabetes

by BGI GenomicsClinical information of the collected samples. (A) The age distribution of the normal group and GDM group. (B) The weight distribution of the normal group and GDM group. (C) The sample
Diabetes & Endocrinology March 14,2024
cfDNA sequencing enhances non-invasive early detection of gestational diabetes

cfDNA sequencing enhances non-invasive early detection of gestational diabetes

by BGI GenomicsClinical information of the collected samples. (A) The age distribution of the normal group and GDM group. (B) The weight distribution of the normal group and GDM group. (C) The sample
Diabetes & Endocrinology March 14,2024
Loss of cells in pancreas in the elderly may cause age-related diabetes

Loss of cells in pancreas in the elderly may cause age-related diabetes

by Tokyo Metropolitan UniversityTwo different ways in which islet cell loss can be observed (top left and right) . The relationship between the percentage of pancreatic beta cells and islet cell
Diabetes & Endocrinology March 14,2024
Loss of cells in pancreas in the elderly may cause age-related diabetes

Loss of cells in pancreas in the elderly may cause age-related diabetes

by Tokyo Metropolitan UniversityTwo different ways in which islet cell loss can be observed (top left and right) . The relationship between the percentage of pancreatic beta cells and islet cell
Diabetes & Endocrinology March 14,2024
What Is Heart Failure With Preserved Ejection Fraction?

What Is Heart Failure With Preserved Ejection Fraction?

ByShamard Charles, MD, MPHUpdated on May 25, 2022Medically reviewed byRichard N. Fogoros, MDAbout half of all people withheart failurehave a heart that pumps normal
Cardiovascular Diseases March 14,2024
What Is Heart Failure With Preserved Ejection Fraction?

What Is Heart Failure With Preserved Ejection Fraction?

ByShamard Charles, MD, MPHUpdated on May 25, 2022Medically reviewed byRichard N. Fogoros, MDAbout half of all people withheart failurehave a heart that pumps normal
Cardiovascular Diseases March 14,2024
Insulin-inhibitory receptor research offers hope for type 2 diabetes therapy

Insulin-inhibitory receptor research offers hope for type 2 diabetes therapy

by Verena Schulz,Helmholtz Association of German Research CentresCentral inceptor immunoreactivity is restricted to neurons, including those regulating energy and glucose metabolism. Credit:&nbs
Diabetes & Endocrinology March 14,2024
Insulin-inhibitory receptor research offers hope for type 2 diabetes therapy

Insulin-inhibitory receptor research offers hope for type 2 diabetes therapy

by Verena Schulz,Helmholtz Association of German Research CentresCentral inceptor immunoreactivity is restricted to neurons, including those regulating energy and glucose metabolism. Credit:&nbs
Diabetes & Endocrinology March 14,2024
What Is Fear of Traveling (Hodophobia)?

What Is Fear of Traveling (Hodophobia)?

Learn more about hodophobia and how to seek treatmentByMichelle C. Brooten-Brooks, LMFTPublished on October 29, 2021Medically reviewed bySteven Gans, MDFear of travel, or hodop
Cardiovascular Diseases March 14,2024
What Is Fear of Traveling (Hodophobia)?

What Is Fear of Traveling (Hodophobia)?

Learn more about hodophobia and how to seek treatmentByMichelle C. Brooten-Brooks, LMFTPublished on October 29, 2021Medically reviewed bySteven Gans, MDFear of travel, or hodop
Cardiovascular Diseases March 14,2024
Shifting focus: Investigators describe changes to pancreatic β cells at onset of type 1 diabetes

Shifting focus: Investigators describe changes to pancreatic β cells at onset of type 1 diabetes

by Joslin Diabetes CenterIn vivo AAV8-mediated overexpression of Mettl3 in NOD mouse β-cells delays T1D progression. Credit:Nature Cell Biology(2024). DOI: 10.1038/s41556-024-01368-0A
Diabetes & Endocrinology March 14,2024
Shifting focus: Investigators describe changes to pancreatic β cells at onset of type 1 diabetes

Shifting focus: Investigators describe changes to pancreatic β cells at onset of type 1 diabetes

by Joslin Diabetes CenterIn vivo AAV8-mediated overexpression of Mettl3 in NOD mouse β-cells delays T1D progression. Credit:Nature Cell Biology(2024). DOI: 10.1038/s41556-024-01368-0A
Diabetes & Endocrinology March 14,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com